Share on StockTwits

Shares of Danaher (NYSE:DHR) have received a consensus rating of “Buy” from the seventeen analysts that are presently covering the company, American Banking News reports. Four analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $73.07.

A number of research firms have recently commented on DHR. Analysts at Zacks reiterated a “neutral” rating on shares of Danaher in a research note on Friday, August 8th. They now have a $78.00 price target on the stock. Separately, analysts at Robert W. Baird raised their price target on shares of Danaher from $40.00 to $41.00 in a research note on Friday, August 1st. They now have an “outperform” rating on the stock. Finally, analysts at Barclays raised their price target on shares of Danaher from $80.00 to $83.00 in a research note on Friday, July 18th.

Shares of Danaher (NYSE:DHR) opened at 76.33 on Monday. Danaher has a 52 week low of $64.78 and a 52 week high of $81.14. The stock’s 50-day moving average is $75.82 and its 200-day moving average is $76.13. The company has a market cap of $53.483 billion and a P/E ratio of 20.69.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 17th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.01. The company had revenue of $5.00 billion for the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter in the previous year, the company posted $0.87 earnings per share. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. Analysts expect that Danaher will post $3.67 EPS for the current fiscal year.

Danaher Corporation (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.